part time job

Cologuard® Gains FDA Approval For Use In Younger Americans, Ages 45 To 49

MADISON, Wis., Sept. 23, 2019 /PRNewswire/ — Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) approved its noninvasive colorectal cancer screening test, Cologuard, for eligible average-risk individuals ages 45 and older, expanding on…